This Week in Psychedelics - 4.24.20

ThisWeekinPsychedelics.png

Cannabis

  • Lebanon Passes Legislation Legalizing Medical Marijuana Cultivation As Economy Struggles Amid Coronavirus Fallout (Newsweek)

  • Mexican Supreme Court Again Extends Marijuana Legalization Deadline (Marijuana Moment)

  • Due to COVID-19, Connecticut’s Legislative Session Cut Short, Cannabis Legalization Stalled (Cannabis Wire)

  • On 4/20, ACLU Highlights Racist Marijuana Enforcement In New Report (Forbes)

  • Virginia Lawmakers Reject Governor’s Delay Of Marijuana Legalization Study (Marijuana Moment)

  • Scotland is set to get its first legal cannabis farm to produce drug for use in medicine (The Scottish Sun)

  • Majority Of Americans Think Marijuana Legalization Is A Successful Policy, Poll Finds (Marijuana Moment)

  • Americans Think Cannabis Is Safer Than Alcohol, But Social Stigmas Remain (MERRY JANE)

  • Early exposure to cannabis boosts young brains' sensitivity to cocaine, rodent study finds (Science Daily)

  • New Jersey Voters Set To Approve Marijuana Legalization Referendum, Poll Shows (Marijuana Moment)

  • Clinical Trials for Treating COVID-19 with Cannabis Begin in Israel (MERRY JANE)

  • Everything to Know About Cannabis and Coronavirus (The Cut)

  • Cannabis industry launches COVID-19 relief efforts in Colorado (KDVR)

  • DEA Marijuana Scheduling Lawsuit Will Be Appealed To Supreme Court Following Dismissal (Marijuana Moment)

  • 24 Million Americans Will Spend Stimulus Check on Weed or Booze, Survey Says (MERRY JANE)

  • New Jerseyans back referendum to legalize weed by huge margin, new poll shows (New Jersey Globe)

  • Lawmakers File Bill To Let Marijuana Businesses Access Federal Coronavirus Relief Funds (Marijuana Moment)

  • Feast or famine: The effect of marijuana on weight (The Spokesman-Review)

  • Smoking Weed Causes Less DNA Damage Than Tobacco, Study Finds (MERRY JANE)

  • There is no difference between the effects of indica and sativa marijuana strains, scientists say (Insider)

  • Weed advocacy groups call for prison depopulation to slow COVID-19 spread (Mugglehead)

LSD

  • Mick Jagger once bought a giant mansion while tripping on LSD (Far Out Magazine)

Magic Mushrooms

  • Until Next Time: California’s Mushroom Decriminalization Effort Ends (Filter)

  • Empower Clinics launches psilocybin research and psychedelic treatment subsidiary (Proactive Investors)

  • Champignon secures stable psilocybin supply for traumatic brain injury, PTSD studies at the University of Miami (Proactive Investors)

  • Two New Crystalline Forms of Norpsilocin (Psychedelic Science Review)

Ketamine

  • Defense Department Approves Ketamine-Based Antidepressant for Some Patients (Military.com)

  • Utah Clinician Exemplifies Innovation in Ketamine Therapy (Lucid News)

Miscellaneous

  • D.C. Would Vote To Decriminalize Psychedelics, Poll Shows (Forbes)

  • Medical Researchers Worry Silicon Valley Could Screw Up Psychedelics (OneZero)

  • Thiel Backs Psychedelic-Drug Startup in Latest Funding Round (Bloomberg)

  • The Prohibited Medicine (Medium)

  • Why Dark-Web Drug Marketplaces Can Be a Refuge (Filter)

  • The Structure and Function of the Serotonin 5-HT2C Receptor (Psychedelic Science Review)

  • How the Illicit Drug Trade Is Adapting to the Coronavirus Pandemic (World Politics Review)

  • UN Experts Agree – The Right to Health of People Who Use Drugs Must Be Prioritised in Global COVID-19 Response (TalkingDrugs)

  • Welcome to Entheogen (Medium)

  • Psychedelics Make a Comeback as Therapies for Brain Injury, PTSD, Anxiety and Even Addiction (BioSpace)

  • Can Psychedelics Treat Climate Grief? (The Nation)

  • Russian NGO Accused of “Narco-Propaganda” Over COVID-19 Advocacy For People Who Use Drugs (TalkingDrugs)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.